Hyperfine (HYPR) EBT Growth (3y) (2024 - 2026)
Hyperfine (HYPR) EBT Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -2.47% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 7.77% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 0.70% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 37.81% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 4.82% |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 61.06% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -2.57% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 32.11% |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 14.40% |
| 10 | Hyperfine | 137.26 Mn | 95.98 Mn | 1.98 Mn | 10.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.83% |
| Dec 31, 2025 | 23.22% |
| Sep 30, 2025 | 5.77% |
| Jun 30, 2025 | 26.42% |
| Mar 31, 2025 | 26.56% |
| Dec 31, 2024 | 26.42% |
| Sep 30, 2024 | 14.28% |
| Jun 30, 2024 | 11.35% |
| Mar 31, 2024 | -8.11% |